Two years ago, the World Health Organization (WHO) declared COVID-19 a “pandemic.” We look back at key activities from BIO and the biopharmaceutical industry—and where we go from here.

Adding to the wide-scale human suffering across Ukraine, Russia’s unprovoked invasion of Ukraine is causing a major disruption to both medical as well as agricultural supply chains in the region and worldwide. As Russia’s war destabilizes the lives of millions of Ukrainians, it also destabilizes…

With Katherine Tai confirmed unanimously by the Senate as the U.S. Trade Representative (USTR) and Secretary of Agriculture Tom Vilsack in place at the U.S. Department of Agriculture (USDA), the world is now getting a better picture of what U.S. agricultural policy – and the role of biotechnology…

As the country tries to loosen COVID’s grip on society, efforts are focused on reestablishing economic viability while protecting public health. Quite a tall order considering the effects of climate change have been threatening public health long before the coronavirus outbreak, and will only…

Biotechnology companies, large and small, are working hard to more effectively treat and safely prevent the spread of COVID-19. For an episode of the I AM BIO Podcast, BIO President & CEO Jim Greenwood was joined by Dr. George Scangos, CEO of Vir and head of BIO’s Coronavirus Collaboration…

Months into the Coronavirus pandemic, scientists and researchers around the globe are still hunting for treatments and vaccines for the COVID-19 virus. In a recent episode of the I AM BIO podcast, BIO President and CEO Jim Greenwood spoke with Dr. John Maraganore, CEO of Alnylam Pharmaceuticals,…

With Mother's Day just around the corner, BIO sat down with Dr. Mary-Ann Etiebet, Executive Director of Merck for Mothers, for a discussion about how Merck helping address maternal health needs in the United States and in countries impacted by COVID-19.  BIO: What is Merck for…

With America’s scientists and researchers working around the clock to eradicate COVID-19, BIO President and CEO Jim Greenwood checked in with Dr. Jeremy Levin. Dr. Levin is CEO of Ovid Therapeutics and Chairman of BIO’s board of directors. In a recent edition of the I AM BIO podcast, Dr. Levin…

As countless people, companies, and organizations work together to combat the COVID-19 pandemic, one company is working to eradicate the virus itself at record speed. BIO CEO Jim Greenwood recently spoke with Stéphane Bancel, CEO of Moderna, which is racing to develop a vaccine to stop this deadly…

Many companies in the biotechnology industry are working to find new ways to combat the COVID-19 pandemic. On a recent I AM BIO podcast, BIO CEO Jim Greenwood sat down with Dr. George Yancopoulos, Regeneron’s President, Co-Founder, and Chief Scientific Officer, about how his team is responding and…